Bezlotoxumab May Cut Recurrent C. Diff in IBD (CME/CE)

(MedPage Today) -- Small post-hoc analysis found trend to 50% reduction in recurrence

Source: MedPage Today Gastroenterology - September 21, 2018 Category: Gastroenterology Source Type: news